Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Bioorg Med Chem Lett. 2012 Feb 24;22(7):2376–2379. doi: 10.1016/j.bmcl.2012.02.055

Table 1.

Anti-HIV activities of 9a9e in cellular assay and aqueous solubilitya

graphic file with name nihms360128u1.jpg
R1 EC50 (nM)b CC50 (μM)c SId Aqueous Solubility (μg/mL)
pH 7.4 pH 2.0
9a COOCH3 2.74 ± 0.71 >22.8 >8465 1.30 1.75
9b COOH 230 ± 38 14.9 65 117 4.40
9c CONH2 0.87 ± 0.28 >23.6 >27126 0.63 2.10
9d CONHCH3 5.72 ± 0.94 >9.2 >1606 1.32 8.63
9e CH2OH 0.53 ± 0.13 16.3 30754 3.23 21.0
3e NO2 0.38 ± 0.07 >47.1 >123947 0.29 0.29
2 (TMC278) 0.52 ± 0.14 19.4 37305 0.24 156
a

HIV-1 NL3-4 (wild-type) virus in TZM-bl cell lines.

b

Concentration of compound that causes 50% inhibition of viral replication and presented as mean ± standard deviation (SD) in at least triplicate.

c

Concentration of compound that causes cytotoxicity to 50% of cells.

d

Selectivity index (SI) is the ratio of CC50/EC50.

e

Compound and activity data were published previously12